These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF Camacho-Villegas TA; Mata-González MT; García-Ubbelohd W; Núñez-García L; Elosua C; Paniagua-Solis JF; Licea-Navarro AF Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614715 [TBL] [Abstract][Full Text] [Related]
3. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3. Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542 [TBL] [Abstract][Full Text] [Related]
4. Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development. Ubah OC; Steven J; Kovaleva M; Ferguson L; Barelle C; Porter AJR; Barelle CJ Front Immunol; 2017; 8():1780. PubMed ID: 29312310 [TBL] [Abstract][Full Text] [Related]
5. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles. Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR Front Immunol; 2022; 13():953917. PubMed ID: 36177031 [TBL] [Abstract][Full Text] [Related]
6. [Progress in shark single-domain antibody]. Liu X; Chen Q Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058 [TBL] [Abstract][Full Text] [Related]
7. Ancient species offers contemporary therapeutics: an update on shark V English H; Hong J; Ho M Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195 [TBL] [Abstract][Full Text] [Related]
12. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Roth D; Piekarek M; Paulsson M; Christ H; Bloch W; Krieg T; Davidson JM; Eming SA Am J Pathol; 2006 Feb; 168(2):670-84. PubMed ID: 16436680 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
14. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation. Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci. Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of the chimeric plasmin-resistant VEGF165/VEGF183 (132-158) protein in murine breast cancer induces distinct vascular patterning adjacent to tumors and retarded tumor growth. Zhang HY; Fan BL; Wu XS; Mu LM; Wang WF; Zhu WL Mol Med Rep; 2015 Feb; 11(2):1483-9. PubMed ID: 25373557 [TBL] [Abstract][Full Text] [Related]
17. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark ( Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957 [TBL] [Abstract][Full Text] [Related]
18. VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry. Häsler J; Flajnik MF; Williams G; Walsh FS; Rutkowski JL Mol Immunol; 2016 Jul; 75():28-37. PubMed ID: 27213814 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody. Cheong WS; Leow CY; Abdul Majeed AB; Leow CH Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922 [TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]